NPCE vs STE · rev $79.9M vs P/E 25, rev $5.46B
Neuropace Inc (NPCE) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
NPCE currently screens at market cap $312.2M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the NPCE and STE stock pages for the full models.
Not investment advice.